The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | Common | 004225108 | 25,209 | 792,499 | SH | SOLE | 792,499 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | Common | 00771V108 | 18,870 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| AGENUS INC | Common | 00847G705 | 26,680 | 3,715,938 | SH | SOLE | 3,715,938 | 0 | 0 | ||
| AGENUS INC | Common | 00847G705 | 800 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
| AGIOS PHARMACEUTICALS INC | Common | 00847X104 | 7,923 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | Common | 00972D105 | 8,548 | 944,579 | SH | SOLE | 944,579 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259103 | 5,327 | 3,575,000 | SH | SOLE | 3,575,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 27,305 | 3,689,857 | SH | SOLE | 3,689,857 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 909 | 45,203 | SH | SOLE | 45,203 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 1,933 | 268,119 | SH | SOLE | 268,119 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 6,083 | 1,379,402 | SH | SOLE | 1,379,402 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 38,832 | 419,712 | SH | SOLE | 419,712 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO. | Common | 110122108 | 21,561 | 399,875 | SH | SOLE | 399,875 | 0 | 0 | ||
| CASCADIAN THERAPEUTICS INC | Common | 14740B101 | 9,203 | 5,611,323 | SH | SOLE | 5,611,323 | 0 | 0 | ||
| CELLECTIS - ADR | Sponsored ADR | 15117K103 | 1,413 | 58,671 | SH | SOLE | 58,671 | 0 | 0 | ||
| CEMPRA INC | Common | 15130J109 | 726 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | Common | 221015100 | 4,415 | 268,369 | SH | SOLE | 268,369 | 0 | 0 | ||
| DERMIRA INC | Common | 24983L104 | 27,256 | 805,926 | SH | SOLE | 805,926 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | Common | 253031108 | 271 | 46,082 | SH | SOLE | 46,082 | 0 | 0 | ||
| FORTRESS BIOTECH INC | Common | 34960Q109 | 4,029 | 1,356,636 | SH | SOLE | 1,356,636 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS | Common | 37890U108 | 20,037 | 869,263 | SH | SOLE | 869,263 | 0 | 0 | ||
| GW PHARMACEUTICALS PLC | ADS | 36197T103 | 17,733 | 133,600 | SH | SOLE | 133,600 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 23,869 | 7,344,177 | SH | SOLE | 7,344,177 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 53 | 300,800 | SH | Call | SOLE | 300,800 | 0 | 0 | |
| INNOCOLL HOLDINGS PLC | Shares | G4783X105 | 2,720 | 468,148 | SH | SOLE | 468,148 | 0 | 0 | ||
| LION BIOTECHNOLOGIES INC | Common | 53619R102 | 35,038 | 4,257,347 | SH | SOLE | 4,257,347 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 9,839 | 1,488,487 | SH | SOLE | 1,488,487 | 0 | 0 | ||
| NANTKWEST INC | Common | 63016Q102 | 563 | 72,412 | SH | SOLE | 72,412 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | Common | 64125C109 | 24,843 | 490,582 | SH | SOLE | 490,582 | 0 | 0 | ||
| NEURODERM LTD | Common | M74231107 | 12,690 | 686,303 | SH | SOLE | 686,303 | 0 | 0 | ||
| ONCOBIOLOGICS INC | Common | 68235M105 | 1,916 | 450,872 | SH | SOLE | 450,872 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT A | Warrant | 68235M113 | 112 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT B | Warrant | 68235M121 | 233 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| ONCOMED PHARMACEUTICALS INC | Common | 68234X102 | 972 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| PROTEOSTASIS THERAPEUTICS INC | Common | 74373B109 | 2,799 | 179,565 | SH | SOLE | 179,565 | 0 | 0 | ||
| PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 2,050 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
| SAREPTA THERAPUTICS INC | Common | 803607100 | 84,126 | 1,369,909 | SH | SOLE | 1,369,909 | 0 | 0 | ||
| SAREPTA THERAPUTICS INC | Common | 803607100 | 6,033 | 190,000 | SH | Call | SOLE | 190,000 | 0 | 0 | |
| SAREPTA THERAPUTICS INC | Common | 803607100 | 2 | 75,600 | SH | Put | SOLE | 75,600 | 0 | 0 | |
| SEATTLE GENETICS INC | Common | 812578102 | 7,642 | 141,500 | SH | SOLE | 141,500 | 0 | 0 | ||
| SORRENTO THERAPEUTICS INC | Common | 83587F202 | 11,852 | 1,531,273 | SH | SOLE | 1,531,273 | 0 | 0 | ||
| TELIGENT INC | Common | 87960W104 | 12,447 | 1,637,819 | SH | SOLE | 1,637,819 | 0 | 0 | ||
| TESARO INC | Common | 881569107 | 27,837 | 277,703 | SH | SOLE | 277,703 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 4,671 | 316,020 | SH | SOLE | 316,020 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | Common | 921659108 | 13,773 | 827,693 | SH | SOLE | 827,693 | 0 | 0 | ||
| VERACYTE INC | Common | 92337F107 | 6,990 | 918,556 | SH | SOLE | 918,556 | 0 | 0 | ||
| VERICEL CORP | Common | 92346J108 | 604 | 215,744 | SH | SOLE | 215,744 | 0 | 0 | ||
| VERSARTIS INC | Common | 92529L102 | 1,173 | 95,742 | SH | SOLE | 95,742 | 0 | 0 | ||